Medicine & Health

Researchers at the School of Medicine found that metabolism-boosting, bile acid-reducing drugs improved gut health in mice. The findings indicate a new approach that may help malnourished children with stunted growth.

Researchers at the School of Medicine have determined how Eastern equine encephalitis virus attaches to a receptor it uses to enter and infect cells. The findings lay a foundation for treatments and vaccines for viral infections.

Gary Weil, MD, a professor of medicine and of molecular microbiology at the School of Medicine, received the 2023 Kyelem Prize at the Coalition for Operational Research on Neglected Tropical Diseases’ annual meeting.

Todd A. Fehniger, MD, PhD, and co-principal investigators Jeffrey J. Bednarski, MD, PhD, and Thomas Pfeiffer, MD, all at the School of Medicine, have received a total of $1.4 million from the Leukemia & Lymphoma Society, the Rising Tide Foundation for Clinical Cancer Research and Siteman Kids to support a clinical trial of a novel cell-based immunotherapy.

Research led by Rajendra S. Apte, MD, PhD, at the School of Medicine, is the focus of a $15 million pledge from philanthropist Jeffrey T. Fort to accelerate research and develop new treatments for diseases that cause vision loss.

New research from the School of Medicine and the Veterans Affairs St. Louis Health Care System comparing the viruses that cause the flu and COVID-19 shows that people hospitalized with seasonal influenza also can suffer long-term negative health effects.

Hrishikesh S. Kulkarni, MD, an assistant professor of medicine in the Division of Pulmonary & Critical Care Medicine at the School of Medicine, has received the 2023 Svar Complement Excellence Award from the International Complement Society and life sciences company Svar.

David T. Curiel, MD, PhD, and James W. Janetka, PhD, professors at the School of Medicine, have been elected fellows of the National Academy of Inventors.

Washington University in St. Louis researchers will adapt their COVID-19-detecting breathalyzer to one that can also screen for common seasonal viruses with a two-year $3.6 million grant from Flu Lab. With the funding, they plan to take the technology from bench into clinical trials with the goal of preparing the handheld rapid screening breath test for commercial application and FDA registration.

Michelle Oyen, an associate professor of biomedical engineering at the McKelvey School of Engineering, has been named among the 200 Trailblazing Leaders in Women’s Health and FemTech for 2023 by Women of Wearables.